Trial Profile
Duloxetine Versus Placebo in the Acute Treatment of Patients With Major Depressive Disorder and Associated Painful Physical Symptoms.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Feb 2012
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Major depressive disorder; Pain
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 28 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 13 Dec 2010 Planned End Date changed from 1 Apr 2011 to 1 Mar 2011 as reported by ClinicalTrials.gov.